Literature DB >> 15065217

Locomotor sensitization to cocaine in rats with olfactory bulbectomy.

R Andrew Chambers1, Teige Sheehan, Jane R Taylor.   

Abstract

Olfactory bulbectomy in rats has been suggested as a comprehensive animal model of affective disorders associated with an array of behavioral changes, responsivity to chronic antidepressant treatment, and alterations in limbic structures thought to be critical in the pathophysiology of affective disorders. Recent work showing increased motivational responsivity to amphetamine suggests that olfactory bulbectomy could also be a useful animal model of dual diagnosis disorders. To further investigate this possibility, we studied locomotor activity in olfactory bulbectomized rats 14 days postsurgery in response to novelty and upon acute and repeated injections of cocaine (15/mg/kg) or saline. Consistent with prior studies, lesioned animals showed greater locomotor activity in response to a novel environment and significantly heightened locomotor activation upon initial cocaine exposure. Over 7 days of repeated cocaine injections, lesioned animals also showed a presensitized pattern of activity, with a loss of incremental increases in locomotion observed in control animals. Daily saline injections produced no group differences in pre- or postinjection activity, while cocaine-treated bulbectomized rats demonstrated a decline in their daily preinjection activity. These results suggest that neural alterations caused by olfactory bulbectomy produce altered behavioral response patterns to repeated doses of cocaine, and support the study of olfactory bulbectomy as a useful neurobehavioral model for understanding substance use disorder comorbidity in mental illness. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15065217     DOI: 10.1002/syn.20017

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  10 in total

1.  Evaluation of reward processes in an animal model of depression.

Authors:  David A Slattery; Athina Markou; John F Cryan
Journal:  Psychopharmacology (Berl)       Date:  2006-12-20       Impact factor: 4.530

2.  Ethanol sensitization in a neurodevelopmental lesion model of schizophrenia in rats.

Authors:  Susan K Conroy; Zachary Rodd; R Andrew Chambers
Journal:  Pharmacol Biochem Behav       Date:  2006-08-28       Impact factor: 3.533

3.  Animal Modeling and Neurocircuitry of Dual Diagnosis.

Authors:  R Andrew Chambers
Journal:  J Dual Diagn       Date:  2007-03

4.  Endocannabinoid modulation of amphetamine sensitization is disrupted in a rodent model of lesion-induced dopamine dysregulation.

Authors:  Sarah A Eisenstein; Philip V Holmes; Andrea G Hohmann
Journal:  Synapse       Date:  2009-11       Impact factor: 2.562

Review 5.  A scale-free systems theory of motivation and addiction.

Authors:  R Andrew Chambers; Warren K Bickel; Marc N Potenza
Journal:  Neurosci Biobehav Rev       Date:  2007-05-03       Impact factor: 8.989

6.  Simultaneous anhedonia and exaggerated locomotor activation in an animal model of depression.

Authors:  Thomas Romeas; Marie-Claude Morissette; Ouissame Mnie-Filali; Graciela Piñeyro; Sandra M Boye
Journal:  Psychopharmacology (Berl)       Date:  2009-04-29       Impact factor: 4.530

7.  Certain or uncertain cocaine expectations influence accumbens dopamine responses to self-administered cocaine and non-rewarded operant behavior.

Authors:  Manoranjan S D'Souza; Christine L Duvauchelle
Journal:  Eur Neuropsychopharmacol       Date:  2008-05-21       Impact factor: 4.600

8.  A role for 2-arachidonoylglycerol and endocannabinoid signaling in the locomotor response to novelty induced by olfactory bulbectomy.

Authors:  Sarah A Eisenstein; Jason R Clapper; Philip V Holmes; Daniele Piomelli; Andrea G Hohmann
Journal:  Pharmacol Res       Date:  2010-01-05       Impact factor: 7.658

9.  Neonatal amygdala lesions: co-occurring impact on social/fear-related behavior and cocaine sensitization in adult rats.

Authors:  R Andrews Chambers; Tammy J Sajdyk; Susan K Conroy; Joan E Lafuze; Stephanie D Fitz; Anantha Shekhar
Journal:  Behav Neurosci       Date:  2007-12       Impact factor: 1.912

10.  Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms.

Authors:  Petra Amchova; Jana Kucerova; Valentina Giugliano; Zuzana Babinska; Mary T Zanda; Maria Scherma; Ladislav Dusek; Paola Fadda; Vincenzo Micale; Alexandra Sulcova; Walter Fratta; Liana Fattore
Journal:  Front Pharmacol       Date:  2014-03-20       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.